Pharmafit Provence

Professional product catalogue

Osteoporosis medicines

Osteoporosis medicines act on bone remodelling through different mechanisms. Bisphosphonates and selected biological agents form part of this category's vocabulary, with specific oral or injectable presentations. Osteoporosis concerns bone fragility and fracture risk rather than simply joint pain. Understanding bone resorption, formation and molecular targets distinguishes these medicines from analgesics and nutritional products in the wider bone-health environment. A shared association with bones does not establish one pharmaceutical family, one route or the same documented role for every substance or product.

Products in this category

131 products